chr11-103184969-A-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 4P and 5B. PM1PM2BP4_StrongBP6
The ENST00000375735.7(DYNC2H1):c.6551A>T(p.Asp2184Val) variant causes a missense change. The variant allele was found at a frequency of 0.000149 in 1,611,332 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000375735.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYNC2H1 | NM_001080463.2 | c.6551A>T | p.Asp2184Val | missense_variant | 41/90 | ENST00000650373.2 | NP_001073932.1 | |
DYNC2H1 | NM_001377.3 | c.6551A>T | p.Asp2184Val | missense_variant | 41/89 | ENST00000375735.7 | NP_001368.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYNC2H1 | ENST00000650373.2 | c.6551A>T | p.Asp2184Val | missense_variant | 41/90 | NM_001080463.2 | ENSP00000497174 | A1 | ||
DYNC2H1 | ENST00000375735.7 | c.6551A>T | p.Asp2184Val | missense_variant | 41/89 | 1 | NM_001377.3 | ENSP00000364887 | P3 | |
DYNC2H1 | ENST00000334267.11 | c.2205+50550A>T | intron_variant | 1 | ENSP00000334021 | |||||
DYNC2H1 | ENST00000649323.1 | c.*4096A>T | 3_prime_UTR_variant, NMD_transcript_variant | 39/51 | ENSP00000497581 |
Frequencies
GnomAD3 genomes AF: 0.000915 AC: 139AN: 151916Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000189 AC: 47AN: 248402Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134764
GnomAD4 exome AF: 0.0000678 AC: 99AN: 1459298Hom.: 0 Cov.: 30 AF XY: 0.0000537 AC XY: 39AN XY: 725916
GnomAD4 genome AF: 0.000927 AC: 141AN: 152034Hom.: 1 Cov.: 32 AF XY: 0.000915 AC XY: 68AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 17, 2020 | The sequence change, c.6551A>T, in exon 41 that results in an amino acid change, p.Asp2184Val. This sequence change has been previously reported in product of conception samples of a couple with recurrent miscarriages in the compound heterozygous state along with other missense change, p.Tyr2016Cys, in the same gene (PMID: 26826164). No functional studies were performed. This sequence change has been described in the gnomAD database with a low population frequency of 0.32% in the African subpopulation (dbSNP rs201967064). The p.Asp2184Val change affects a moderately conserved amino acid residue located in a domain of the DYNC2H1 protein that is known to be functional. The p.Asp2184Val substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Asp2184Val change remains unknown at this time. - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 20, 2024 | Variant summary: DYNC2H1 c.6551A>T (p.Asp2184Val) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a neutral effect of the variant on protein function. The variant allele was found at a frequency of 0.00019 in 248402 control chromosomes, predominantly at a frequency of 0.0028 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is slightly higher than the estimated maximal expected allele frequency for a pathogenic variant in DYNC2H1 causing Short-rib thoracic dysplasia phenotype (0.0025), suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.6551A>T has been reported in the literature in one individual affected with recurrent early pregnancy loss. These report(s) do not provide unequivocal conclusions about association of the variant with Short-rib thoracic dysplasia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 26826164). ClinVar contains an entry for this variant (Variation ID: 281769). Based on the evidence outlined above, the variant was classified as likely benign. - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 28, 2015 | - - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 26, 2022 | Identified in the the heterozygous state in an indvidual whose partner had recurrent miscarriage and was heterozygous for another variant in the DYNC2H1 gene (Qiao et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26826164) - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 25, 2018 | The DYNC2H1 c.6551A>T; p.Asp2184Val variant (rs201967064, ClinVar variant ID 281769) was found in the compound heterozygous state along with another DYNC2H1 variant (p.Tyr2016Cys) in two miscarriages from a family with recurrant pregnancy loss (Qiao 2106). This variant is listed in the genome Aggregation Database (gnomAD) with an African population frequency of 0.3% (identified on 75 out of 23,960 chromosomes). The aspartic acid at position 2184 is moderately conserved, considering 28 species, and computational analyses of the effects of the p.Asp2184Val variant on protein structure and function do not predict a deleterious effect (SIFT: tolerated, PolyPhen-2: benign). Based on the available information, the clinical significance of the p.Asp2184Val variant cannot be determined with certainty. - |
DYNC2H1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 12, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Jeune thoracic dystrophy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at